Skip to main content
. Author manuscript; available in PMC: 2018 Oct 10.
Published in final edited form as: ACS Biomater Sci Eng. 2017 May 15;3(6):1017–1026. doi: 10.1021/acsbiomaterials.7b00039

Figure 3.

Figure 3

Representative Western blot of MUC5AC and MUC5B mucins from HBE culture washings from a donor with cystic fibrosis treated with COS, COS-NO, COS-SPA, and COS-SPA-NO for 2 h at 25 °C at concentrations ranging from 0 to 20 mg/mL.